The aqueous extract of Albizia adianthifolia leaves attenuates 6-hydroxydopamine-induced anxiety, depression and oxidative stress in rat amygdala

BMC Complementary and Alternative Medicine

Lucian Hritcu³  Marius Mihasan³  Théophile Dimo¹  Harquin Simplice Foyet⁴  Alain Bertrand Dongmo²  Galba Jean Beppe⁴ 

[1] Laboratory of Animal Physiology, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon;Laboratory of Animal Biology and Physiology, University of Douala, Douala, Cameroon;Department of Biology, Alexandru Ioan Cuza University of Iasi, Bd. Carol I, No. 11, Iasi, Romania;Department of Biological Sciences, Faculty of Science, University of Maroua, Maroua, Cameroon

关键词: Parkinson’s disease;    Antidepressant-like effect;    Anxiolytic-like effect;    6-hydroxydopamine-lesioned model;    Albizia adianthifolia leaves extract;   

Others  :  1233225
DOI  :  10.1186/s12906-015-0912-0

 received in 2014-12-13, accepted in 2015-10-13,  发布年份 2015

【 摘 要 】

Background

While the Albizia adianthifolia (Schumach.) W. Wright (Fabaceae) is a traditional herb largely used in the African traditional medicine as analgesic, purgative, antiinflammatory, antioxidant, antimicrobial, memory-enhancer, anxiolytic and antidepressant drug, there are no scientific data that clarify the anxiolytic and antidepressant-like effects in 6-hydroxydopamine (6-OHDA)-lesioned animal model of Parkinson’s disease. This study was undertaken in order to identify the effects of aqueous extract of A. adianthifolia leaves on 6-hydroxydopamine-induced anxiety, depression and oxidative stress in the rat amygdala.

Methods

The effect of the aqueous extract of A. adianthifolia leaves (150 and 300 mg/kg, orally, daily, for 21 days) on anxiety and depression was assessed using elevated plus-maze and forced swimming tests, as animal models of anxiety and depression. Also, the antioxidant activity in the rat amygdala was assessed using assessed using superoxide dismutase, glutathione peroxidase and catalase specific activities, the total content of the reduced glutathione, protein carbonyl and malondialdehyde levels. Statistical analyses were performed using by one-way analysis of variance (ANOVA). Significant differences were determined by Tukey’s post hoc test. F values for which p < 0.05 were regarded as statistically significant. Pearson’s correlation coefficient and regression analysis were used in order to evaluate the connection between behavioral measures, the antioxidant defence and lipid peroxidation.

Results

6-OHDA-lesioned rats exhibited the following: decrease of the exploratory activity, the percentage of the time spent and the number of entries in the open arm within elevated plus-maze test and decrease of swimming time and increase of immobility time within forced swimming test. Administration of the aqueous extract significantly exhibited anxiolytic- and antidepressant-like effects and also antioxidant potential in the rat amygdala.

Conclusions

Our results suggest that the aqueous extract ameliorates 6-OHDA-induced anxiety and depression by attenuation of the oxidative stress in the rat amygdala. These pieces of evidence accentuate its use in traditional medicine.

【 授权许可】

   
2015 Beppe et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

Fig. 6.

【 参考文献 】

• [1]Collier TJ, Kanaan NM, Kordower JH. Ageing as a primary risk factor for Parkinson’s disease: evidence from studies of non-human primates. Nat Rev Neurosci. 2011; 12:359-66.
• [2]Barone P. Treatment of depressive symptoms in Parkinson’s disease. Eur J Neurol. 2011; 18:11-5.
• [3]Schwarz J, Odin P, Buhmann C, Csoti I, Jost W, Wüllner U et al.. Depression in Parkinson’s disease. J Neurol. 2011; 258:336-8.
• [4]Leentjens AFG, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P. Anxiety rating scales in Parkinson’s disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Movement Disord. 2011; 26:407-15.
• [5]Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y et al.. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease. Neurobiol Dis. 2006; 22:421-34.
• [6]Hritcu L, Ciobica A, Artenie V. Effects of right-unilateral 6-hydroxydopamine infusion-induced memory impairment and oxidative stress: relevance for Parkinson’s disease. Cent Eur J Biol. 2008; 3:250-7.
• [7]Akirav I, Maroun M. The role of the medial prefrontal cortex-amygdala circuit in stress effects on the extinction of fear. Neural Plasticity. 2007; 2007:30873.
• [8]Chen L, Liu J, Zhang QJ, Feng JJ, Gui ZH, Ali U et al.. Alterations of emotion, cognition and firing activity of the basolateral nucleus of the amygdala after partial bilateral lesions of the nigrostriatal pathway in rats. Brain Res Bull. 2011; 85:329-38.
• [9]Kitayama T, Onitsuka Y, Song L, Morioka N, Morita K, Dohi T. Assessing an eating disorder induced by 6-OHDA and the possibility of nerve regeneration therapy by transplantation of neural progenitor cells in rats. Nihon Shinkei Seishin Yakurigaku Zasshi. 2007; 27:109-16.
• [10]Hefco V, Yamada K, Hefco A, Hritcu L, Tiron A, Nabeshima T. Role of the mesotelencephalic dopamine system in learning and memory processes in the rat. Eur J Pharmacol. 2003; 475:55-60.
• [11]Patil SP, Jain PD, Sancheti JS, Ghumatkar PJ, Tambe R, Sathaye S. Neuroprotective and neurotrophic effects of apigenin and luteolin in MPTP induced parkinsonism in mice. Neuropharmacology. 2014; 86:192-202.
• [12]Perier C, Vila M. Mitochondrial Biology and Parkinson’s Disease. Cold Spring Harb Perspect Med. 2012; 2:a009332.
• [13]Stafford GI, Pedersen ME, van Staden J, Jäger AK. Review on plants with CNS-effects used in traditional South African medicine against mental diseases. J Ethnopharmacol. 2008; 119:513-37.
• [14]Kim W-K, Jung JW, Ahn NY, Oh HR, Lee BK, Oh JK et al.. Anxiolytic-like effects of extracts from Albizzia julibrissin bark in the elevated plus-maze in rats. Life Sci. 2004; 75:2787-95.
• [15]Jung Y-H, Ha R-R, Kwon S-H, Hong S-I, Lee K-H, Kim S-Y et al.. Anxiolytic effects of Julibroside C1 isolated from Albizzia julibrissin in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 44:184-92.
• [16]Beppe G, Dongmo A, Foyet H, Tsabang N, Olteanu Z, Cioanca O et al.. Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease. BMC Complement Altern Med. 2014; 14:142. BioMed Central Full Text
• [17]Sanjay K. Saponins of Albizia lebbek in Alzheimer’s and Parkinson’s disease. IJMPR. 2003; 19:42-8.
• [18]Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. Academic Press, London; 2007.
• [19]Franklin AE, Engeland CG, Kavaliers M, Ossenkopp K-P. Lipopolysaccharide-induced hypoactivity and behavioral tolerance development are modulated by the light–dark cycle in male and female rats. Psychopharmacology. 2003; 170:399-408.
• [20]Herrera-Marschitz M, Arbuthnott G, Ungerstedt U. The rotational model and microdialysis: Significance for dopamine signalling, clinical studies, and beyond. Prog Neurobiol. 2010; 90:176-89.
• [21]Rajendra Kopalli S, Koppula S, Young Shin K, Noh S-J, Jin Q, Yeon Hwang B et al.. SF-6 attenuates 6-hydroxydopamine-induced neurotoxicity: An in vitro and in vivo investigation in experimental models of Parkinson’s disease. J Ethnopharmacol. 2012; 143:686-94.
• [22]Hayashi Y, Sogabe S, Hattori Y, Tanaka J. Anxiolytic and hypnotic effects in mice of roasted coffee bean volatile compounds. Neurosci Lett. 2012; 531:166-9.
• [23]Rodgers RJ, Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev. 1997; 21:801-10.
• [24]Campos M, Fernandes E, Ferreira J, Santos AS, Calixto J. Antidepressant-like effects of Trichilia catigua (Catuaba) extract: evidence for dopaminergic-mediated mechanisms. Psychopharmacol (Berl). 2005; 182:45-53.
• [25]Winterbourn C, Hawkins R, Brian M, Carrell R. The estimation of red cell superoxide dismutase activity. J Lab Clin Med. 1975; 85:337.
• [26]Sharma M, Gupta Y. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci. 2002; 7:2489-98.
• [27]Sinha A. Colorimetric assay of catalase. Anal Biochem. 1972; 47:389-94.
• [28]Fukuzawa A, Tokumura A. Glutathione peroxidase activity in tissues of vitamin E-deficient mice. J Nutr Sci Vitaminol (Tokyo). 1976; 22:405-7.
• [29]Oliver C, Ahn B, Moerman E, Goldstein S, Stadtman E. Age-related changes in oxidized proteins. J Biol Chem. 1987; 262:5488-91.
• [30]Luo S, Wehr N. Protein carbonylation: avoiding pitfalls in the 2,4-dinitrophenylhydrazine assay. Redox Rep. 2009; 14:159-66.
• [31]Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95:351-8.
• [32]Smith P, Krohn R, Hermanson G, Mallia A, Gartner F, Provenzano M et al.. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150:76-85.
• [33]Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA et al.. Current Protocol in Molecular Biology. Wiley-Interscience, New York; 2002.
• [34]Bonito Oliva A, Masini D, Fisone G. A mouse model of non-motor symptoms in Parkinson’s disease: focus on pharmacological interventions targeting affective dysfunctions. Front Behav Neurosci. 2014; 8:290.
• [35]Kumar D, Bhat ZA. Apigenin 7-glucoside from Stachys tibetica Vatke and its anxiolytic effect in rats. Phytomedicine. 2014; 21:1010-4.
• [36]Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang L-J, Guttman M et al.. Preferential loss of serotonin markers in caudate versus putamen in Parkinson’s disease. Brain. 2008; 131:120-31.
• [37]Mansouri MT, Soltani M, Naghizadeh B, Farbood Y, Mashak A, Sarkaki A. A possible mechanism for the anxiolytic-like effect of gallic acid in the rat elevated plus maze. Pharmacol Biochem Behav. 2014; 117:40-6.
• [38]Adebesin IF, Akindele AJ, Adeyemi OO. Evaluation of neuropharmacological effects of aqueous leaf extract of Albizia glaberrima (Leguminosae) in mice. J Ethnopharmacol. 2015; 160:101-8.
• [39]Emamghoreishi M, Khasaki M, Aazam MF. Coriandrum sativum: evaluation of its anxiolytic effect in the elevated plus-maze. J Ethnopharmacol. 2005; 96:365-70.
• [40]Savić MM, Kukić JM, Grayer RJ, Milinković MM, Marin PD, Divljaković J et al.. Behavioural characterization of four endemic Stachys taxa. Phytother Res. 2010; 24:1309-16.
• [41]Cioanca O, Hritcu L, Mihasan M, Hancianu M. Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid β(1–42) rat model of Alzheimer’s disease. Physiol Behav. 2013; 120:193-202.
• [42]Tolardo R, Zetterman L, Bitencourtt DR, Mora TC, de Oliveira FL, Biavatti MW et al.. Evaluation of behavioral and pharmacological effects of Hedyosmum brasiliense and isolated sesquiterpene lactones in rodents. J Ethnopharmacol. 2010; 128:63-70.
• [43]Drui G, Carnicella S, Carcenac C, Favier M, Bertrand A, Boulet S et al.. Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson’s disease. Mol Psychiatry. 2014; 19:358-67.
• [44]Jesse CR, Bortolatto CF, Savegnago L, Rocha JBT, Nogueira CW. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32:1838-43.
• [45]Caspani O, Reitz M-C, Ceci A, Kremer A, Treede R-D. Tramadol reduces anxiety-related and depression-associated behaviors presumably induced by pain in the chronic constriction injury model of neuropathic pain in rats. Pharmacol Biochem Behav. 2014; 124:290-6.
• [46]Baluchnejadmojarad T, Roghani M, Mafakheri M. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: Involvement of estrogen receptors and oxidative stress. Neurosci Lett. 2010; 480:206-10.
• [47]Zare K, Eidi A, Roghani M, Rohani A. The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat. Metab Brain Dis. 2015;30:205-13.
• [48]Foyet HS, Hritcu L, Ciobica A, Stefan M, Kamtchouing P, Cojocaru D. Methanolic extract of Hibiscus asper leaves improves spatial memory deficits in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease. J Ethnopharmacol. 2011; 133:773-9.
• [49]Zafir A, Ara A, Banu N. In vivo antioxidant status: A putative target of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33:220-8.
• [50]Avallone R, Zanoli P, Puia G, Kleinschnitz M, Schreier P, Baraldi M. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochem Pharmacol. 2000; 59:1387-94.